How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.

In our 'Marketing Excellence' themed month Sunil Ramkali discusses how to deliver an effective pharmaceutical ... brand plan until we know what is required to drive brand sales.

The Rights Plan will automatically expire on October 30, 2025, without any further action being required to be taken by ... About Eagle Pharmaceuticals, Inc. Eagle is a fully integrated pharmaceutical ...

Capping more than two years of stock-gyrating drama, Pfizer said it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another ...

Massachusetts House Democrats released a $61 billion spending plan for fiscal year 2026 that does not include a series of tax ...

Singapore's trade minister said on Wednesday that he cannot rule out a recession for the local economy this year following ...

Q2 2025 Results Conference Call April 16, 2025 9:00 PM ETCompany ParticipantsEstelle Riva - Investor RelationsFrancois Thibault ...

J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its profit outlook while raising its sales forecast.

Industry and Commerce Minister Nqobizitha Ndlovu has called for urgent action to address the challenges stifling the competitiveness of Zimbabwe's ...

Keros Therapeutics halted phase 2 of TROPOS, but KER-065 shows promise in DMD and financial stability ensures growth ...

In recent past, U.S President Trump had signalled at potential tariffs on pharma imports as well, calling for bringing overseas manufacturing back to America.

European equities have started the week with a positive trading day, but with investors still reeling from one of the wildest ...